Literature DB >> 32304323

Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.

Earnest James Paul Daniel1, Matilde Las Rivas2, Erandi Lira-Navarrete2, Ana García-García2, Ramon Hurtado-Guerrero2,3,4,5, Henrik Clausen3,4, Thomas A Gerken1,6,7.   

Abstract

A family of polypeptide GalNAc-transferases (GalNAc-Ts) initiates mucin-type O-glycosylation, transferring GalNAc onto hydroxyl groups of Ser and Thr residues of target substrates. The 20 GalNAc-T isoenzymes in humans are classified into nine subfamilies according to sequence similarity. GalNAc-Ts select their sites of glycosylation based on weak and overlapping peptide sequence motifs, as well prior substrate O-GalNAc glycosylation at sites both remote (long-range) and neighboring (short-range) the acceptor. Together, these preferences vary among GalNAc-Ts imparting each isoenzyme with its own unique specificity. Studies on the first identified GalNAc-Ts showed Thr acceptors were preferred over Ser acceptors; however studies comparing Thr vs. Ser glycosylation across the GalNAc-T family are lacking. Using a series of identical random peptide substrates, with single Thr or Ser acceptor sites, we determined the rate differences (Thr/Ser rate ratio) between Thr and Ser substrate glycosylation for 12 isoenzymes (representing 7 GalNAc-T subfamilies). These Thr/Ser rate ratios varied across subfamilies, ranging from ~2 to ~18 (for GalNAc-T4/GalNAc-T12 and GalNAc-T3/GalNAc-T6, respectively), while nearly identical Thr/Ser rate ratios were observed for isoenzymes within subfamilies. Furthermore, the Thr/Ser rate ratios did not appreciably vary over a series of fixed sequence substrates of different relative activities, suggesting the ratio is a constant for each isoenzyme against single acceptor substrates. Finally, based on GalNAc-T structures, the different Thr/Ser rate ratios likely reflect differences in the strengths of the Thr acceptor methyl group binding to the active site pocket. With this work, another activity that further differentiates substrate specificity among the GalNAc-Ts has been identified.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 O-glycan biosynthesis; GALNT; glycosyltransferase; mucin-type O-glycosylation; peptide acceptor

Year:  2020        PMID: 32304323      PMCID: PMC7581654          DOI: 10.1093/glycob/cwaa036

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  75 in total

1.  De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.

Authors:  Kirstine Lavrsen; Sally Dabelsteen; Sergey Y Vakhrushev; Asha M R Levann; Amalie Dahl Haue; August Dylander; Ulla Mandel; Lars Hansen; Morten Frödin; Eric P Bennett; Hans H Wandall
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

2.  Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.

Authors:  Thomas A Gerken; Oliver Jamison; Cynthia L Perrine; Jeremy C Collette; Helen Moinova; Lakshmeswari Ravi; Sanford D Markowitz; Wei Shen; Himatkumar Patel; Lawrence A Tabak
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

3.  Glycosyltransferase genes that cause monogenic congenital disorders of glycosylation are distinct from glycosyltransferase genes associated with complex diseases.

Authors:  Hiren J Joshi; Lars Hansen; Yoshiki Narimatsu; Hudson H Freeze; Bernard Henrissat; Eric Bennett; Hans H Wandall; Henrik Clausen; Katrine T Schjoldager
Journal:  Glycobiology       Date:  2018-05-01       Impact factor: 4.313

4.  TAILS N-terminomics and proteomics reveal complex regulation of proteolytic cleavage by O-glycosylation.

Authors:  Sarah L King; Christoffer K Goth; Ulrich Eckhard; Hiren J Joshi; Amalie D Haue; Sergey Y Vakhrushev; Katrine T Schjoldager; Christopher M Overall; Hans H Wandall
Journal:  J Biol Chem       Date:  2018-03-28       Impact factor: 5.157

5.  O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids.

Authors:  Katrine T-B G Schjoldager; Malene B Vester-Christensen; Eric Paul Bennett; Steven B Levery; Tilo Schwientek; Wu Yin; Ola Blixt; Henrik Clausen
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

6.  Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-12 in gastric and colonic cancer cell lines and in human colorectal cancer.

Authors:  Jian-Ming Guo; Hui-Li Chen; Guo-Min Wang; Yong-Kang Zhang; Hisashi Narimatsu
Journal:  Oncology       Date:  2004       Impact factor: 2.935

7.  cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3.

Authors:  E P Bennett; H Hassan; H Clausen
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

Review 8.  Polypeptide GalNAc-Ts: from redundancy to specificity.

Authors:  Matilde de Las Rivas; Erandi Lira-Navarrete; Thomas A Gerken; Ramon Hurtado-Guerrero
Journal:  Curr Opin Struct Biol       Date:  2019-01-28       Impact factor: 6.809

9.  N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.

Authors:  Chen Wu; Xiaodan Guo; Weina Wang; Yun Wang; Yaojun Shan; Bo Zhang; Wenqian Song; Sisi Ma; Jianfeng Ge; Hao Deng; Mingsheng Zhu
Journal:  BMC Cancer       Date:  2010-04-01       Impact factor: 4.430

10.  Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.

Authors:  Neeley Remmers; Judy M Anderson; Erin M Linde; Dominick J DiMaio; Audrey J Lazenby; Hans H Wandall; Ulla Mandel; Henrik Clausen; Fang Yu; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2013-02-27       Impact factor: 12.531

View more
  6 in total

Review 1.  Polypeptide N-acetylgalactosamine transferase 3: a post-translational writer on human health.

Authors:  Yohana Camila Garay; Romina Beatriz Cejas; Virginia Lorenz; Natacha Zlocowski; Pedro Parodi; Franco Alejandro Ferrero; Genaro Angeloni; Valentina Alfonso García; Victor German Sendra; Ricardo Dante Lardone; Fernando José Irazoqui
Journal:  J Mol Med (Berl)       Date:  2022-09-02       Impact factor: 5.606

2.  Immunoglobulin A Glycosylation and Its Role in Disease.

Authors:  Alyssa L Hansen; Colin Reily; Jan Novak; Matthew B Renfrow
Journal:  Exp Suppl       Date:  2021

3.  Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in Colorectal Cancer.

Authors:  Makiko Ogawa; Atsushi Tanaka; Kei Namba; Jinru Shia; Julia Y Wang; Michael H Roehrl
Journal:  Front Oncol       Date:  2022-05-27       Impact factor: 5.738

4.  ISOGlyP: de novo prediction of isoform-specific mucin-type O-glycosylation.

Authors:  Jonathon E Mohl; Thomas A Gerken; Ming-Ying Leung
Journal:  Glycobiology       Date:  2021-04-01       Impact factor: 4.313

5.  Atomic and Specificity Details of Mucin 1 O-Glycosylation Process by Multiple Polypeptide GalNAc-Transferase Isoforms Unveiled by NMR and Molecular Modeling.

Authors:  Helena Coelho; Matilde de Las Rivas; Ana S Grosso; Ana Diniz; Cátia O Soares; Rodrigo A Francisco; Jorge S Dias; Ismael Compañon; Lingbo Sun; Yoshiki Narimatsu; Sergey Y Vakhrushev; Henrik Clausen; Eurico J Cabrita; Jesús Jiménez-Barbero; Francisco Corzana; Ramon Hurtado-Guerrero; Filipa Marcelo
Journal:  JACS Au       Date:  2022-02-24

Review 6.  The Role of APP O-Glycosylation in Alzheimer's Disease.

Authors:  Keiko Akasaka-Manya; Hiroshi Manya
Journal:  Biomolecules       Date:  2020-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.